Adelaide Research & Scholarship: Search

Search

Results 1-10 of 16 (Search time: 0.003 seconds).

previous
1
2
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2020	Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML	DiNardo, C.D.; Tiong, I.S.; Quaglieri, A.; MacRaild, S.; Loghavi, S.; Brown, F.C.; Thijssen, R.; Pomilio, G.; Ivey, A.; Salmon, J.; Glytsou, C.; Fleming, S.A.; Zhang, Q.; Ma, H.; Patel, K.P.; Kornblau, S.M.; Xu, Z.; Chua, C.C.; Chen, X.; Blombery, P.; et al.
	2020	The EMT modulator SNAI1 contributes to AML pathogenesis via its interaction with LSD1	Carmichael, C.L.; Wang, J.; Nguyen, T.; Kolawole, O.; Benyoucef, A.; De Mazière, C.; Milne, A.R.; Samuel, S.; Gillinder, K.; Hediyeh-Zadeh, S.; Vo, A.N.Q.; Huang, Y.; Knezevic, K.; McInnes, W.R.L.; Shields, B.J.; Mitchell, H.; Ritchie, M.E.; Lammens, T.; Lintermans, B.; Van Vlierberghe, P.; et al.
	2018	A four-gene lincRNA expression signature predicts risk in multiple cohorts of acute myeloid leukemia patients	Beck, D.; Thoms, J.; Palu, C.; Herold, T.; Shah, A.; Olivier, J.; Boelen, L.; Huang, Y.; Chacon, D.; Brown, A.; Babic, M.; Hahn, C.; Perugini, M.; Zhou, X.; Huntly, B.; Schwarzer, A.; Klusmann, J.-H.; Berdel, W.; Wörmann, B.; Büchner, T.; et al.
	2019	Chromosomal abnormalities and prognosis in NPM1-mutated acute myeloid leukemia: a pooled analysis of individual patient data from nine international cohorts	Angenendt, L.; Röllig, C.; Montesinos, P.; Martínez-Cuadrón, D.; Barragan, E.; García, R.; Botella, C.; Martínez, P.; Ravandi, F.; Kadia, T.; Kantarjian, H.M.; Cortes, J.; Juliusson, G.; Lazarevic, V.; Höglund, M.; Lehmann, S.; Recher, C.; Pigneux, A.; Bertoli, S.; Dumas, P.Y.; et al.
	2023	Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia	Kan, W.L.; Dhagat, U.; Hercus, T.R.; Kaufmann, K.B.; Nero, T.L.; Zeng, A.G.X.; Toubia, J.; Barry, E.F.; Broughton, S.E.; Gomez, G.A.; Dottore, M.; Cheung Tung Shing, K.S.; Thomas, D.; Benard, B.; Simpson, K.J.; Schoof, E.; Goodall, G.J.; Begley, C.G.; Ekert, P.G.; Tvorogov, D.; et al.
	2020	RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML	Brown, A.L.; Arts, P.; Carmichael, C.L.; Babic, M.; Dobbins, J.; Chong, C.-E.; Schreiber, A.W.; Feng, J.; Phillips, K.; Wang, P.P.S.; Ha, T.; Homan, C.C.; King-Smith, S.L.; Rawlings, L.; Vakulin, C.; Dubowsky, A.; Burdett, J.; Moore, S.; McKavanagh, G.; Henry, D.; et al.
	2019	Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia	Moujalled, D.M.; Pomilio, G.; Ghiurau, C.; Ivey, A.; Salmon, J.; Rijal, S.; Macraild, S.; Zhang, L.; Teh, T.C.; Tiong, I.S.; Lan, P.; Chanrion, M.; Claperon, A.; Rocchetti, F.; Zichi, A.; Kraus-Berthier, L.; Wang, Y.; Halilovic, E.; Morris, E.; Colland, F.; et al.
	2016	Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies	Lewinsohn, M.; Brown, A.L.; Weinel, L.M.; Phung, C.; Rafidi, G.; Lee, M.K.; Schreiber, A.W.; Feng, J.; Babic, M.; Chong, C.E.; Lee, Y.; Yong, A.; Suthers, G.K.; Poplawski, N.; Altree, M.; Phillips, K.; Jaensch, L.; Fine, M.; D'Andrea, R.J.; Lewis, I.D.; et al.
	2013	Targeting acute myeloid leukemia by dual inhibition of PI3K signaling and Cdk9-mediated Mcl-1 transcription	Thomas, D.; Powell, J.; Vergez, F.; Segal, D.; Nguyen, N.; Baker, A.; Teh, T.; Barry, E.; Sarry, J.; Lee, E.; Nero, T.; Jabbour, A.; Giovanna, P.; Green, B.; Manenti, S.; Glaser, S.; Parker, M.; Lopez, A.; Ekert, P.; Lock, R.; et al.
	2022	Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia	Bassal, M.A.; Samaraweera, S.E.; Lim, K.; Bernard, B.A.; Bailey, S.; Kaur, S.; Leo, P.; Toubia, J.; Thompson-Peach, C.; Nguyen, T.; Maung, K.Z.Y.; Casolari, D.A.; Iarossi, D.G.; Pagani, I.S.; Powell, J.; Pitson, S.; Natera, S.; Roessner, U.; Lewis, I.D.; Brown, A.L.; et al.